LLY:Lilly (Eli) & Co - Stock Price Quote and Dividend Data
LATEST CLOSE STOCK PRICE
Projected 10 Year Dividend Yield8.19%
Dividend Yield 5 Year Average2.33%
Dividend Payout Ratio30.00%
Dividend Payout Ratio 5 yr Average91.00%
Dividend Growth Rate 3 yr Average9.37%
Dividend Growth Rate 5 yr Average6.43%
Dividend AllStar™ Ranking
Consecutive Dividend Increases5 Years
Dividend Payment TypeStock Split
Dividend Declaration DateDec. 16, 2019
Dividend Ex DateFeb. 13, 2020
Dividend Record DateFeb. 14, 2020
Dividend Pay DateMar. 10, 2020
Dividend Amount Current$0.740
Dividend Amount Previous$0.645
Dividends Paid in the Last 12 Months4
First Dividend Paid1885
52-Week Low/High Stock Price$101.36 - $147.87
Percent Held by Institutions62.92%
PE Ratio to Industry31%
Debt-Equity to Industry1.34%
Total Return Last 12 Months12.01%
Total Return Last 3 Years77.52%
Total Return Last 5 Years115.29%
Latest Trade DateApr. 02, 2020
No Data available for Payment History.
Eli Lilly and Company discovers, develops, manufactures, and markets products in a single business segment: human pharmaceutical products. Co.'s human pharmaceutical products include: diabetes and other endocrinology products, immunology products, neuroscience products, oncology products, and other products. Co.'s diabetes and other endocrinology products include: Baqsimi® and Basaglar®. Co.'s immunology products include: Olumiant® and Taltz®. Co.'s neuroscience products include: Cymbalta® and Emgality®. Co.'s oncology products include: Alimta®, Cyramza®, Erbitux® and Verzenio®. Co.'s other products include: Cialis®.
SegmentPharmaceuticals & Biotechnology
Dividend AllStar™ Ranking
Direct Purchase Minimum$1,000
Optional Cash Pay Min-Max$50 - $150,000/yr
Optional Cash Payment FrequencyWeekly
Mar. 27, 2020CLOSE PRICE INCREASE: Lilly (Eli) & Co (NYSE: LLY) on 03-27-2020 increased close price > 10% from $121.94 to $134.35Read more...
Mar. 18, 2020CLOSE PRICE INCREASE: Lilly (Eli) & Co (NYSE: LLY) on 03-18-2020 increased close price > 10% from $129.38 to $143.20Read more...
Mar. 14, 2020CLOSE PRICE INCREASE: Lilly (Eli) & Co (NYSE: LLY) on 03-14-2020 increased close price > 10% from $126.02 to $139.37Read more...
Apr. 03, 2020CLOSE PRICE DECREASE: Zelda Therapeutics Ltd (OTCBB: ZLDAF) on 04-03-2020 decreased close price > 10% from $0.02 to $0.02Read more...
Apr. 03, 2020CLOSE PRICE DECREASE: Exagen Inc (NASDAQ: XGN) on 04-03-2020 decreased close price > 10% from $14.42 to $12.75Read more...
Apr. 03, 2020CLOSE PRICE DECREASE: Xeris Pharmaceuticals Inc (NASDAQ: XERS) on 04-03-2020 decreased close price > 10% from $1.76 to $1.56Read more...